WebDisclosure WebDisclosure
Basculer en Français
8722 Companies
153289 Keywords
88814 Articles
82382 Press releases
Headlines Articles Press releases Dr. Jen Welter Remove
  1. Home
  2. Companies
  3. Dr. Jen Welter
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/18/2024 at 23:22, 1 year 4 months ago

    Dr. Jen Welter to Host 'A Day in the Life: The Ultimate Insiders Experience for Women' in Las Vegas Ahead of the Big Game. DraftKings Set as Title Sponsor

    Dr. Jen Welter, the groundbreaking NFL coach and two-time Gold medalist, is set to revolutionize the Big Game experience for women with 'A Day in the Life: Women's Big Game Experience,' a unique and empowering event in collaboration with DraftKings. Attendees will enjoy VIP treatment, celebrity coaches, and the chance to learn and play football in a supportive environment.
    A Day In The Life Women's Big Game Experience Dr. Jen Welter DraftKings Empowering Women In Sports
Accesswire
  • Published on 06/18/2025 at 15:15, 31 minutes ago

    Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging

  • Published on 06/18/2025 at 15:00, 46 minutes ago

    iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025

  • Published on 06/18/2025 at 14:50, 56 minutes ago

    Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA

  • Published on 06/18/2025 at 14:30, 1 hour 16 minutes ago

    Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones

  • Published on 06/18/2025 at 14:30, 1 hour 16 minutes ago

    MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology

View all ACCESSWIRE
EQS Group
  • Published on 06/18/2025 at 15:30, 16 minutes ago

    Hong Kong Baptist University and Elsevier Report Highlights Global Expansion of Chinese Medicine Research, Urges Standardised Frameworks for Broader Integration

  • Published on 06/18/2025 at 15:29, 17 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated

  • Published on 06/18/2025 at 15:28, 18 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.

  • Published on 06/18/2025 at 15:27, 18 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc

  • Published on 06/18/2025 at 15:27, 19 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Aviva plc

View all EQS
Les Echos
  • Published on 06/18/2025 at 14:21, 1 hour 25 minutes ago

    Definitieve resultaten van de kapitaalverhoging

  • Published on 06/18/2025 at 14:21, 1 hour 25 minutes ago

    Final results of the capital increase

  • Published on 06/18/2025 at 14:21, 1 hour 25 minutes ago

    Final results of the capital increase

  • Published on 06/18/2025 at 09:39, 6 hours 7 minutes ago

    Eerste fase van het openbaar aanbod in het kader van een kapitaalverhoging is succesvol afgerond waarbij reeds werd ingeschreven op ongeveer 75,56% van de Nieuwe Aandelen Lancering van een versnelde private plaatsing van Scrips

  • Published on 06/18/2025 at 09:39, 6 hours 7 minutes ago

    First phase of the public offering in the framework of the capital increase has been successfully completed with about 75.56% of the New Shares already subscribed Launch of an accelerated private placement of Scrips

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy